Marcello Marelli
Overview
Explore the profile of Marcello Marelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
936
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Molinari F, Marelli M, Berretti E, Serrecchia S, Coppola R, De Cesare F, et al.
Polymers (Basel)
. 2025 Feb;
17(3).
PMID: 39940528
As population growth and climate change intensify pressures on agriculture, innovative strategies are vital for ensuring food security, optimizing resources, and protecting the environment. This study introduces a novel approach...
2.
Nervig C, Rice M, Marelli M, Christie R, Owen S
Bioconjug Chem
. 2025 Jan;
36(2):190-202.
PMID: 39841105
Antibodies have gained clinical success in the last two decades for the targeted delivery of highly toxic small molecule chemotherapeutics. Yet antibody-drug conjugates (ADCs) often fail in the clinic due...
3.
Berger J, Terruzzi S, Bunzen H, Ballerini F, Vandone M, Marelli M, et al.
Small
. 2025 Jan;
21(6):e2408137.
PMID: 39777914
Within the material family of metal-organic frameworks (MOFs) the subclass of flexible MOFs (flexMOFs) has attracted great attention, showing structural flexibility as a response to external stimuli such as guest...
4.
Marelli M, Perez Schmidt P, Nguyen X, Pitzalis E, Poggini L, Ragona L, et al.
Nanoscale
. 2024 Oct;
16(42):19669-19674.
PMID: 39385674
We describe here the synthesis of ultrasmall Pt nanoparticles (NPs) obtained by a robust and reliable protocol using UV-Vis photoreduction of a platinum salt precursor, under continuous flow conditions. These...
5.
Moore E, Rice M, Roy G, Zhang W, Marelli M
Xenobiotica
. 2024 Sep;
54(8):469-491.
PMID: 39329289
Antibody drug conjugates are an exciting therapeutic modality that combines the targeting specificity of antibodies with potent cytotoxins to selectively kill cancer cells. The targeting component improves efficacy and protects...
6.
Frigerio R, Musico A, Strada A, Bergamaschi G, Panella S, Grange C, et al.
J Extracell Biol
. 2024 Jun;
1(8):e53.
PMID: 38939054
Despite their clinical potential, Extracellular Vesicles (EVs) struggle to take the scene as a preeminent source of biomarkers in liquid biopsy. Limitations in the use of EVs origin from their...
7.
Vaughan H, Est-Witte S, Dockery L, Urello M, Boyd J, Keyser B, et al.
Sci Technol Adv Mater
. 2024 May;
25(1):2351791.
PMID: 38817250
Targeted nanoparticles offer potential to selectively deliver therapeutics to cells; however, their subcellular fate following endocytosis must be understood to properly design mechanisms of drug release. Here we describe a...
8.
Salerno G, Palladino P, Marelli M, Polito L, Minunni M, Berti D, et al.
Nanomaterials (Basel)
. 2024 May;
14(9).
PMID: 38727388
The reversibility of the covalent interaction between boronic acids and 1,2- or 1,3-diols has put the spotlight on this reaction for its potential in the development of sensors and for...
9.
Cacaci M, Biagiotti G, Toniolo G, Albino M, Sangregorio C, Severi M, et al.
Nanomaterials (Basel)
. 2023 May;
13(10).
PMID: 37242002
The increasing resistance of bacteria to conventional antibiotics represents a severe global emergency for human health. The broad-spectrum antibacterial activity of silver has been known for a long time, and...
10.
Zhang L, Aragon-Sanabria V, Aditya A, Marelli M, Cao T, Chen F, et al.
Adv Ther (Weinh)
. 2023 Apr;
6(3).
PMID: 37007587
Despite advances by recently approved antibody-drug conjugates in treating advanced gastric cancer patients, substantial limitations remain. Here, several key obstacles are overcome by developing a first-in-class ultrasmall (sub-8-nanometer (nm)) anti-human...